PHILADELPHIA, PA (www.sep.benfranklin.org) – Ben Franklin Technology Partners of Southeastern Pennsylvania (BFTP/SEP) recently approved $2,075,000 in funding for eleven early-stage companies.
Companies approved for funding:
Biomeme, Inc. – Philadelphia – Approved Investment: $400,000
Biomeme's technology platform transforms a user’s smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time qPCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures.
To read the original article: Ben Franklin
